Sambrinvest
Venture capitalCharleroi · Series A–Late Stage · 13 people tracked
Find your way into Sambrinvest
1,998 people in our graph share verified history with the Sambrinvest team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Sambrinvest provides financing solutions tailored to the needs of small and medium-sized enterprises, primarily in Belgium. With a portfolio of over 300 companies, the firm emphasizes close, proactive, and long-term support for entrepreneurs, offering not only capital but also active board participation, sector expertise (including medtech), and hands-on accompaniment through the early and difficult stages of a company's development. It positions itself as a key player in the Belgian market able to help structure a range of financing arrangements.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from curated & public directories
What they invest in
from 8 of 9 portfolio companiesBiotech ×6Healthtech ×6Deep Tech ×5Medical Devices ×4Advanced Manufacturing ×1AI & Machine Learning ×1Digital Health ×1Hardware ×1
HQs:Belgium×6
Investments · 9 tracked
founders shown can be your intro pathBy year:2023 · 12022 · 12 dated
AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases.
BiotechHealthtech
Ignacio Anegon(Co-founder, Senior Consultant & SAB Member)inCarole Guillonneau(Co-founder & Head of Research)inFrançois-Xavier Hubert(Co-founder, Past President & Board Member)
Co-investorsCriteria Bio VenturesNewton BiocapitalSound BioventuresWallonie Entreprendre
ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.
BiotechHealthtechMedical Devices
Dr. Mark Throsby(Chief Executive Officer)
Co-investorsMRL Ventures FundV-Bio VenturesVIVES PartnersEQT Life SciencesWallonie Entreprendre
ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations.
BiotechDeep TechDigital HealthHealthtechMedical DevicesGhent, BE
Xavier Saelens(Scientific Founder)Nico Callewaert(Scientific Founder)inMike Garrett(Chief Executive Officer)
Co-investorsV-Bio VenturesUCB VenturesVIBFund+VIVES Partners
Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders.
BiotechDeep TechHealthtechMedical Devices
Benoit Vanhollebeke(Scientific Founder)inDenis Bedoret(Executive Director)in
Co-investorsNewton BiocapitalWallonie Entreprendre
Theodorus is a Belgian seed-stage venture capital firm that invests in and supports researchers and entrepreneurs building science-based companies.
BiotechDeep Tech
Co-investorsFinance.BrusselsFonds de solidarité FTQSofinaTeralys CapitalSeido Capital
Aerospacelab designs, builds, and operates satellites and satellite platforms for Earth observation, intelligence, and connectivity missions.
Deep TechHardwareSpace TechNot specified on page, BE
Benoît Deper(Founder)in
Co-investorsAirbus VenturesXAngeEuropean Investment Bank
Santero is a Belgium-based biotech company developing antibacterial drugs, including an RSH inhibitor programme targeting Pseudomonas aeruginosa and multidrug-resistant pathogens.
AI & Machine LearningBiotechDeep TechHealthtechBrussels, BE
Abel Garcia-Pino(Co-founder & Scientific Advisor)inCédric Govaerts(Co-founder & Scientific Advisor)inMark Beards(Chief Executive Officer)inEmilie Racine(COO & Head of Chemistry)inCuong Vuong(Chief Scientific Officer)inValérie Gallien(Chief of Staff)in
Co-investorsNewton Biocapital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Accountable
Portfolio news
latest coverage across their companiesAerospacelab · newspaceeconomy.ca · Sep 27, 2025
Frequently asked questions
- How many investments has Sambrinvest made?
- Sambrinvest has 9 tracked investments.
- What stage does Sambrinvest invest at?
- Sambrinvest invests at the Series A, Series B, Series C, Late Stage stages.
- What sectors does Sambrinvest focus on?
- Sambrinvest focuses on Advanced Manufacturing, Biotech, Enterprise Software, FoodTech, Hardware, Medical Devices, Mobility & Transportation, New Materials, PropTech, Retail Tech.
- Where is Sambrinvest located?
- Sambrinvest is headquartered in Charleroi, BE.
Images
Similar investors
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
Advent International is a global private equity firm that partners with management teams to build market leaders through buyouts, corporate carve-outs, and value creation across selected sectors.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.